In the absence of TM, the anti-PN-1 blocking antibody had a similar effect in patients with cirrhosis and healthy individuals, namely a change in thrombin generation profile with a higher peak, a higher velocity, and a reduced time to tail, but without any effect on ETP (Table 2, Fig. 2C, and Fig. S1). This evidence concerns the gene SERPINE2 and Cirrhosis.